Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Milestone Pharmaceuticals Inc. (MIST) had Income from Continuous Operations of $-26.07M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$0.24M |
|
$-26.07M |
|
$0.01M |
|
$0.22M |
|
$23.90M |
|
$-23.66M |
|
$-2.40M |
|
$-26.07M |
|
$-26.07M |
|
$-26.07M |
|
|
Income from Continuous Operations |
$-26.07M |
$-26.07M |
|
$-26.07M |
|
$-23.66M |
|
$-23.61M |
|
130.29M |
|
130.29M |
|
$-0.20 |
|
$-0.20 |
|
| Balance Sheet Financials | |
$192.25M |
|
$0.50M |
|
$1.48M |
|
$193.73M |
|
$20.94M |
|
$58.19M |
|
$136.74M |
|
$157.69M |
|
$36.05M |
|
$36.05M |
|
$36.05M |
|
117.79M |
|
| Cash Flow Statement Financials | |
$-16.05M |
|
$-80.03M |
|
$94.35M |
|
$73.05M |
|
$71.32M |
|
$-1.73M |
|
$1.28M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.18 |
|
-- |
|
-- |
|
0.62 |
|
1.61 |
|
94.12% |
|
-9942.44% |
|
-9942.44% |
|
-- |
|
-10952.10% |
|
-10952.10% |
|
$-16.10M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
0.01 |
|
0.08 |
|
1145.80 |
|
-72.31% |
|
-72.31% |
|
-13.45% |
|
-27.66% |
|
$0.31 |
|
$-0.12 |
|
$-0.12 |
|